Celltrion Healthcare, Foreign Investors Net Sell 72,000 Shares... Stock Price -0.79%
As of 2:31 PM on the 6th, Celltrion Healthcare is trading at 151,100 KRW, down 0.79% from the previous day. This represents a 14.58% decrease compared to December 21. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
Today, foreigners have net sold 72,000 shares of Celltrion Healthcare, and institutions have net sold 2,000 shares, according to provisional data. Over the past five days, individual investors have net bought 82,502 shares, while foreigners and institutions have net bought 35,642 shares and net sold 194,270 shares, respectively.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- Woman Experiences Eye Protrusion After 20 Years of Contraceptive Injections, Plans Lawsuit Against Major Pharmaceutical Company
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
